Paper42130643
KRAS Gene Variants rs712 and rs61764370 as Predictive Markers of Breast Cancer Susceptibility in a Bangladeshi Population: A Case-Control Study.
Eva TA and 7 others. Health Sci Rep, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. KRAS Gene Variants rs712 and rs61764370 as Predictive Markers of Breast Cancer Susceptibility in a Bangladeshi Population: A Case-Control Study. Papers, record 42130643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42130643
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- KRAS Gene Variants rs712 and rs61764370 as Predictive Markers of Breast Cancer Susceptibility in a Bangladeshi Population: A Case-Control Study.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34787849 | Association between rs61764370, rs9266, and rs140080026 polymorphisms of the KRAS gene and breast cancer risk in a Mexican population. | Eur Rev Med Pharmacol Sci | 2021 | https://conductscience.org/library/papers/34787849 | PubMed |
| 2 | 33801965 | Targeting KRAS in Cancer: Promising Therapeutic Strategies. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33801965 | PubMed |
| 3 | 38241592 | Breast cancer: A review of risk factors and diagnosis. | Medicine (Baltimore) | 2024 | https://conductscience.org/library/papers/38241592 | PubMed |
| 4 | 27461636 | rs61764370 polymorphism of Kras and risk of cancer in Caucasian population: A meta-analysis. | J Cancer Res Ther | 2016 | https://conductscience.org/library/papers/27461636 | PubMed |
| 5 | 23324806 | The LCS6 polymorphism in the binding site of let-7 microRNA to the KRAS 3'-untranslated region: its role in the efficacy of anti-EGFR-based therapy in metastatic colorectal cancer patients. | Pharmacogenet Genomics | 2013 | https://conductscience.org/library/papers/23324806 | PubMed |
| 6 | 12413631 | Molecular alterations in sporadic breast cancer. | Crit Rev Oncol Hematol | 2002 | https://conductscience.org/library/papers/12413631 | PubMed |
| 7 | 34905391 | Understanding breast cancer as a global health concern. | Br J Radiol | 2022 | https://conductscience.org/library/papers/34905391 | PubMed |
| 8 | 36084384 | Current and future burden of breast cancer: Global statistics for 2020 and 2040. | Breast | 2022 | https://conductscience.org/library/papers/36084384 | PubMed |
| 9 | 32277629 | Protective effect of rs712 polymorphism in a let-7 microRNA-binding of KRAS gene in breast cancer of a Mexican population. | J BUON | 2020 | https://conductscience.org/library/papers/32277629 | PubMed |
| 10 | 18922928 | A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. | Cancer Res | 2008 | https://conductscience.org/library/papers/18922928 | PubMed |
| 11 | 41834461 | Exploring the Relationship Between MDM4 Gene Polymorphisms (rs1380576 and rs4245739) and Breast Cancer Susceptibility in Bangladesh: A Case-Control Study. | J Clin Lab Anal | 2026 | https://conductscience.org/library/papers/41834461 | PubMed |
| 12 | 22436609 | KRAS rs61764370 is associated with HER2-overexpressed and poorly-differentiated breast cancer in hormone replacement therapy users: a case control study. | BMC Cancer | 2012 | https://conductscience.org/library/papers/22436609 | PubMed |
| 13 | 35626173 | Breast Cancer-Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature). | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35626173 | PubMed |
| 14 | 36510353 | Association between KRAS gene polymorphisms and genetic susceptibility to breast cancer in a Chinese population. | J Clin Lab Anal | 2023 | https://conductscience.org/library/papers/36510353 | PubMed |
| 15 | 22662244 | The KRAS-variant is associated with risk of developing double primary breast and ovarian cancer. | PLoS One | 2012 | https://conductscience.org/library/papers/22662244 | PubMed |
| 16 | 34503097 | Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34503097 | PubMed |
| 17 | 30755557 | Knowledge, Attitude and Practice of Bangladeshi Women towards Breast Cancer: A Cross Sectional Study. | Mymensingh Med J | 2019 | https://conductscience.org/library/papers/30755557 | PubMed |
| 18 | 26681038 | Association of a let-7 KRAS rs712 polymorphism with the risk of breast cancer. | Genet Mol Res | 2015 | https://conductscience.org/library/papers/26681038 | PubMed |
| 19 | 29346471 | Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction. | JAMA Oncol | 2018 | https://conductscience.org/library/papers/29346471 | PubMed |
| 20 | 34776511 | KRAS mutation: from undruggable to druggable in cancer. | Signal Transduct Target Ther | 2021 | https://conductscience.org/library/papers/34776511 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42130643 | KRAS Gene Variants rs712 and rs61764370 as Predictive Markers of Breast Cancer Susceptibility in a Bangladeshi Population: A Case-Control Study. | Health Sci Rep | 2026 | https://conductscience.org/library/papers/42130643 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| KRAS | 3845 | PubTator's text mining | https://conductscience.org/library/genes/3845 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42130643
GET https://conductscience.org/api/papers/v1/42130643/references?page=2